Nucleosome repositioning in cardiac reprogramming
PLOS ONE · 2025
DOI: 10.1371/journal.pone.0317718 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS ONE, 2025. Verfasst von Sonalí Harris und 6 weiteren Autor:innen. Beteiligte Einrichtung: Mandel Center for Heart and Vascular Research, The Duke Cardiovascular Research Center, Duke University Medical Center, Durham, NC, United States of …. Hauptthemen laut MEDLINE: Nucleosomes, Cellular Reprogramming, Myocytes, Cardiac. Die Arbeit nennt 20 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NHLBI NIH HHS, Edna and Fred L. Mandel, Jr. Foundation, NHLBI Division of Intramural Research.
Abstract (Originalsprache)
Early events in the reprogramming of fibroblasts to cardiac muscle cells are unclear. While various histone undergo modification and re-positioning, and these correlate with the activity of certain genes, it is unknown if these events are causal or happen in response to reprogramming. Histone modification and re-positioning would be expected to open up chromatin on lineage-specific genes and this can be ascertained by studying nucleosome architecture. We have recently developed a set of tools to identify significant changes in nucleosome architecture which we used to study skeletal muscle differentiation. In this report, we have applied these tools to understand nucleosome architectural changes during fibroblast to cardiac muscle reprogramming. We found that nucleosomes surrounding the transcription start sites of cardiac muscle genes induced during reprogramming were insensitive to reprogramming factors as well as to agents which enhance reprogramming efficacy. In contrast, significant changes in nucleosome architecture were observed distal to the transcription start site. These regions were associated with nucleosome build-up. In summary, investigations into nucleosome structure do not support the notion that fibroblasts to cardiac muscle cell reprogramming involves chromatin opening and suggests instead long-range effects such as breaking closed-loop inhibition.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Mandel Center for Heart and Vascular Research, The Duke Cardiovascular Research Center, Duke University Medical Center, Durham, NC, United States of America.
ORCID-Profile: Conrad P Hodgkinson
Förderung
- NHLBI NIH HHS
- Edna and Fred L. Mandel, Jr. Foundation
- NHLBI Division of Intramural Research
Zitieren
APA
Harris, S., Baksh, S. S., Wang, X., Anwar, I., Pratt, R. E., Dzau, V. J., & Hodgkinson, C. P. (2025). Nucleosome repositioning in cardiac reprogramming. PLOS ONE. https://doi.org/10.1371/journal.pone.0317718
Vancouver
Harris S, Baksh SS, Wang X, Anwar I, Pratt RE, Dzau VJ, et al. Nucleosome repositioning in cardiac reprogramming. PLOS ONE. 2025. doi:10.1371/journal.pone.0317718
BibTeX
@article{Harris2025,
author = {Harris, Sonalí and Baksh, Syeda S and Wang, Xinghua and Anwar, Iqra and Pratt, Richard E and Dzau, Victor J and Hodgkinson, Conrad P},
title = {Nucleosome repositioning in cardiac reprogramming},
journal = {PLOS ONE},
year = {2025},
doi = {10.1371/journal.pone.0317718}
}
EUVIMED